Innovaro Pharmalicensing

Innovaro Pharmalicensing is a premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide.

Actively supporting all forms of partnering and in- and out-licensing activities, Innovaro Pharmalicensing utilizes the unique Partnering Search service and its global network of industry experts to enable companies to identify and engage with appropriate partners around the world.

Innovaro Pharmalicensing, and its sister service Innovaro Medical Device Licensing are actively utilized by over 200,000 industry professionals each month. Innovaro Pharmalicensing is part of Innovaro Inc, listed on AMEX (INV).

 Innovaro Pharmalicensing
View Sample
from this Publisher

Adobe Acrobat
required
 

List of reports from Innovaro Pharmalicensing

< prev 1  2  next >
Legal Aspects Of Outsourcing Contracts In The Pharmaceutical Industry: A Practical Guide
2/1/2006 | published by: Innovaro Pharmalicensing
... exploitation, including preclinical and clinical research, manufacture, logistics and sales. By affording a background to the key legal issues in this field, this provides a manual for individuals new to outsourcing, as well as support ...  |  more...
Search inside this report
$895.00
Partneringdesk Deals and Alliances In Cardiovascular Diseases
1/1/2006 | published by: Innovaro Pharmalicensing
... (USPs and key questions answered) Partneringdesk Deals and alliances in cardiovascular diseases provides a comprehensive summary of the deals and alliances announced in the field between January 2001 and March 2006, and helps in: the ...  |  more...
Search inside this report
$2,495.00
Reissuing pharmaceuticals in the NHS: Challenging the Chain of Trust
10/1/2005 | published by: Innovaro Pharmalicensing
... care. This report examines and questions the introduced DoH policy to show how it may represent a significant challenge to the integrity of the Chain of Trust, which offers protection to both manufacturers and patients. ...  |  more...
Search inside this report
$1,200.00
Partneringdesk deals and alliances in oncology
6/1/2005 | published by: Innovaro Pharmalicensing
... activity • benchmarking deals • comparing the finances of different deal types. Partneringdesk deals and alliances in oncology brings all the relevant partnering deals into one place, providing a ready reference to deal making in ...  |  more...
Search inside this report
$2,495.00
Late Stage Deals: Strategy, Structure and Payment Terms
8/1/2004 | published by: Innovaro Pharmalicensing
... to complex discovery and target research and development deals. Dealmaking has existed since the beginnings of the industry, since the advent of proprietary medications, patents and latter emergence of biotechnology entrepreneurs. The extent of dealmaking ...  |  more...
$1,800.00
Strategies for Biogeneric Success
5/1/2004 | published by: Innovaro Pharmalicensing
... consistently to GMP and demonstrate its essential similarity to originator products? Having made the product, can you get it to market? Having accessed the market, are you able to make a profit from the sales ...  |  more...
$1,800.00
Intellectual Property Strategies for Pharmaceutical Development
5/1/2004 | published by: Innovaro Pharmalicensing
... actions. The report also deals with the different types of inventions that may occur. According to Tufts University in 2003, a new chemical entity (NCE) costs on average US$897 million to develop, including cost of ...  |  more...
$1,200.00
< prev 1  2  next >